Financials Improve Medical Instruments Co., Ltd.

Equities

300030

CNE100000JL3

Advanced Medical Equipment & Technology

End-of-day quote Shenzhen S.E. 06:00:00 2024-04-25 pm EDT 5-day change 1st Jan Change
4.43 CNY 0.00% Intraday chart for Improve Medical Instruments Co., Ltd. +8.31% -42.84%

Valuation

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization 1 2,634 1,590 2,202 3,798 3,293 2,130
Enterprise Value (EV) 1 2,956 1,848 2,422 3,969 3,472 2,333
P/E ratio 213 x -11.7 x 89.1 x 23.2 x 178 x -10.8 x
Yield 0.29% - - 0.26% 0.38% -
Capitalization / Revenue 4.79 x 2.89 x 3.83 x 4.13 x 4.12 x 3 x
EV / Revenue 5.38 x 3.36 x 4.21 x 4.32 x 4.34 x 3.28 x
EV / EBITDA 35.4 x 95.5 x 33.5 x 28.1 x 45.8 x -108 x
EV / FCF -69.6 x -52.2 x 1,395 x 603 x 78.6 x -239 x
FCF Yield -1.44% -1.92% 0.07% 0.17% 1.27% -0.42%
Price to Book 2.76 x 1.96 x 2.63 x 3.8 x 3.29 x 2.72 x
Nbr of stocks (in thousands) 308,796 308,796 308,796 308,796 309,187 309,187
Reference price 2 8.530 5.150 7.130 12.30 10.65 6.890
Announcement Date 4/24/18 4/25/19 3/6/20 4/20/21 4/24/22 4/26/23
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales 1 549.7 550 575.1 919.2 799.8 710.8
EBITDA 1 83.43 19.36 72.37 141 75.86 -21.65
EBIT 1 45.63 -18.83 36.73 103.5 35.21 -60.91
Operating Margin 8.3% -3.42% 6.39% 11.26% 4.4% -8.57%
Earnings before Tax (EBT) 1 16.93 -144.5 37 165.1 23.84 -214.3
Net income 1 11.16 -136.8 26.02 162.5 18.57 -198.3
Net margin 2.03% -24.87% 4.53% 17.68% 2.32% -27.9%
EPS 2 0.0400 -0.4400 0.0800 0.5300 0.0600 -0.6400
Free Cash Flow 1 -42.45 -35.42 1.736 6.578 44.15 -9.78
FCF margin -7.72% -6.44% 0.3% 0.72% 5.52% -1.38%
FCF Conversion (EBITDA) - - 2.4% 4.66% 58.2% -
FCF Conversion (Net income) - - 6.67% 4.05% 237.78% -
Dividend per Share 2 0.0250 - - 0.0320 0.0400 -
Announcement Date 4/24/18 4/25/19 3/6/20 4/20/21 4/24/22 4/26/23
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 322 257 221 171 179 202
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 3.858 x 13.29 x 3.051 x 1.212 x 2.361 x -9.34 x
Free Cash Flow 1 -42.4 -35.4 1.74 6.58 44.2 -9.78
ROE (net income / shareholders' equity) 0.86% -15.8% 3.16% 17.7% 1.94% -20.9%
ROA (Net income/ Total Assets) 1.77% -0.72% 1.52% 3.98% 1.23% -2.25%
Assets 1 629.2 18,934 1,711 4,083 1,506 8,812
Book Value Per Share 2 3.090 2.630 2.710 3.240 3.230 2.540
Cash Flow per Share 2 0.8800 0.7600 0.6400 0.7000 1.120 0.7100
Capex 1 96 50.4 54.4 56.8 71.1 58
Capex / Sales 17.47% 9.16% 9.47% 6.18% 8.88% 8.17%
Announcement Date 4/24/18 4/25/19 3/6/20 4/20/21 4/24/22 4/26/23
1CNY in Million2CNY
Estimates
  1. Stock Market
  2. Equities
  3. 300030 Stock
  4. Financials Improve Medical Instruments Co., Ltd.